Pharmacokinetics of Budesonide Oral Suspension in Children and Adolescents With Eosinophilic Esophagitis

The pharmacokinetic (PK) profile of budesonide oral suspension (BOS) was evaluated during a phase 2, randomized, double-blind, placebo-controlled, dose-ranging study in pediatric patients with eosinophilic esophagitis (EoE) (MPI 101-01/NCT00762073). Non-compartmental methods were used to calculate P...

Descripción completa

Detalles Bibliográficos
Autores principales: Gupta, Sandeep K., Hill, Malcolm, Vitanza, Joanne M., Farber, Robert H., Desai, Nirav K., Williams, James, Song, Ivy H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Short Communications: Gastroenterology: Eosinophilic Gastrointestinal Diseases
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9278710/
https://www.ncbi.nlm.nih.gov/pubmed/35666852
http://dx.doi.org/10.1097/MPG.0000000000003482

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9278710/
https://www.ncbi.nlm.nih.gov/pubmed/35666852
http://dx.doi.org/10.1097/MPG.0000000000003482

Ejemplares similares